miércoles, 22 de junio de 2022

Analysis of Thromboembolic and Thrombocytopenic Events After the AZD1222, BNT162b2, and MRNA-1273 COVID-19 Vaccines in 3 Nordic Countries | Clinical Pharmacy and Pharmacology | JAMA Network Open | JAMA Network

Analysis of Thromboembolic and Thrombocytopenic Events After the AZD1222, BNT162b2, and MRNA-1273 COVID-19 Vaccines in 3 Nordic Countries | Clinical Pharmacy and Pharmacology | JAMA Network Open | JAMA Network

No hay comentarios:

Publicar un comentario